To fast or not to fast? How food could impact on the absorption of kinase inhibitors and its economical value

  • Camillo Porta | c.porta@smatteo.pv.it Editor-in-Chief Medical Oncology IRCCS San Matteo University Hospital Foundation, Pavia, Italy.

Abstract

Presently, cancer patients receiving oral kinase inhibitors are suggested to take the drug with an empty stomach or, in the case of drugs such as Sorafenib which are administered twice daily, at least following a lowfat meal...

Downloads

Download data is not yet available.
Published
2011-12-18
Section
Editorials
Statistics
Abstract views: 689

FULL TEXT: 130
Share it
How to Cite
Porta, C. (2011). To fast or not to fast? How food could impact on the absorption of kinase inhibitors and its economical value. Oncology Reviews, 1(3), 129-130. Retrieved from https://oncologyreviews.org/index.php/or/article/view/oncol.2007.129